Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status von Ricciuti, Biagio, Arbour, Kathryn Cecilia, Lin, Jessica Jiyeong, Vokes, Natalie, Vajdi Hoojghan, Amir, Li, Yvonne Y., Cherniack, Andrew D., Recondo, Gonzalo, Lamberti, Giuseppe, Venkatraman, Deepti, Rizvi, Hira, Egger, Jacklynn V., Plodkowski, Andrew J., Khosrowjerdi, Sara, Digumarthy, Subba R, Nishino, Mizuki, Sholl, Lynette M., Gainor, Justin F., Hellmann, Matthew David, Awad, Mark M.

Volltext